2o3y: Difference between revisions

Revision as of 02:33, 28 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2o3y.png

Template:STRUCTURE 2o3y

Crystal Structure of the Homo sapiens Cytoplasmic Ribosomal Decoding Site in Presence of Paromamine Derivative NB30Crystal Structure of the Homo sapiens Cytoplasmic Ribosomal Decoding Site in Presence of Paromamine Derivative NB30

Template:ABSTRACT PUBMED 17705310

About this StructureAbout this Structure

2O3Y is a Single protein structure. Full crystallographic information is available from OCA.

ReferenceReference

Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites., Kondo J, Hainrichson M, Nudelman I, Shallom-Shezifi D, Barbieri CM, Pilch DS, Westhof E, Baasov T, Chembiochem. 2007 Sep 24;8(14):1700-9. PMID:17705310

Page seeded by OCA on Mon Jul 28 02:33:13 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2o3y.gif|left|200px]]
+{{Seed}}
+[[Image:2o3y.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2o3y|  PDB=2o3y  |  SCENE=  }}
-'''Crystal Structure of the Homo sapiens Cytoplasmic Ribosomal Decoding Site in Presence of Paromamine Derivative NB30'''
+===Crystal Structure of the Homo sapiens Cytoplasmic Ribosomal Decoding Site in Presence of Paromamine Derivative NB30===
-==Overview==
+<!--
-The lack of absolute prokaryotic selectivity of natural antibiotics is widespread and is a significant clinical problem. The use of this disadvantage of aminoglycoside antibiotics for the possible treatment of human genetic diseases is extremely challenging. Here, we have used a combination of biochemical and structural analysis to compare and contrast the molecular mechanisms of action and the structure-activity relationships of a new synthetic aminoglycoside, NB33, and a structurally similar natural aminoglycoside apramycin. The data presented herein demonstrate the general molecular principles that determine the decreased selectivity of apramycin for the prokaryotic decoding site, and the increased selectivity of NB33 for the eukaryotic decoding site. These results are therefore extremely beneficial for further research on both the design of new aminoglycoside-based antibiotics with diminished deleterious effects on humans, as well as the design of new aminoglycoside-based structures that selectively target the eukaryotic ribosome.
+The line below this paragraph, {{ABSTRACT_PUBMED_17705310}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17705310 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17705310}}
 ==About this Structure==
@@ Line 37: / Line 41: @@
 [[Category: Stop codon readthrough]]
 [[Category: Translation inhibition]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 10:17:57 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 02:33:13 2008''